A doctor measuring a patient’s upper-arm blood pressure
ANHE International

Cellular Therapeutics for Type 2 Diabetes

Reversing Insulin Resistance & Restoring Pancreatic Function

Targeting the Root Cause of Metabolic Decline

Traditional diabetes management focuses on managing symptoms through lifelong daily medication or insulin injections. Our advanced cellular management protocols target the actual biological root causes: chronic metabolic inflammation and pancreatic tissue degeneration.

By introducing specialized, high-viability mesenchymal stem cells (MSCs), we aim to systematically reset your body's glucose metabolism environment, allowing damaged organs to heal from within.

A doctor discussing care questions with a visitor

Reversing Insulin Resistance & Restoring Pancreatic Function

01

1. Reversing Insulin Resistance

Stem cells systemic suppress the chronic, low-grade inflammation in fat, liver, and muscle tissues, reactivating dormant insulin receptors and drastically improving cellular glucose uptake.

02

2. Protecting & Repairing Pancreatic Islets

Through powerful paracrine signaling, the introduced cells secrete critical growth factors that protect surviving pancreatic beta cells from apoptosis (cell death) and stimulate localized tissue regeneration.

03

3. Preventing Vascular Complications

Diabetes causes severe long-term damage to microvessels. Cellular therapy accelerates endothelial cell repair, restores systemic vascular elasticity, and lowers the risk of diabetic neuropathy and cardiovascular complications.

The Medical Pilot Zone and Its Regulatory Framework

A clinical reception area with an examination room

Exclusive National Policy Pathways for Advanced Medicine

ANHE INTERNATIONAL proudly operates within China’s sole national-level medical pilot zone—a visionary healthcare sanctuary established by the State Council. This exclusive designation grants us unique, legally sanctioned "First-to-Try" privileges. Here, cutting-edge cellular therapies, international-standard clinical protocols, and next-generation biomedical products are legally approved for patient care years before they become available in the rest of the country.

Every protocol is fully authorized by institutional review boards and processed within state-of-the-art, certified GMP laboratories, ensuring absolute legal protection, international-grade cell viability, and zero contamination.

Backed by Global Scientific & Clinical Consensus

RESEARCH & EVIDENCE
01

The therapeutic potential of stem cell medicine is documented in the world’s most prestigious peer-reviewed medical journals. Our clinical protocols align with the breakthroughs published in:

02

The Lancet & Nature Medicine: Extensive international publications demonstrate that mesenchymal stem cells (MSCs) effectively suppress chronic metabolic inflammation, offering a groundbreaking pathway for reversing insulin resistance.

03

PubMed / NIH National Library of Medicine: Over tens of thousands of registered clinical trials globally validate the safety, high tolerability, and structural regenerative efficacy of targeted cellular therapeutics for metabolic disorders.

04

Science & Cell Stem Cell: Global landmark studies confirm that cellular therapeutics successfully rescue dysfunctional islet cells and promote multi-organ metabolic homeostasis.